Saturn V Capital Management LLC Biocryst Pharmaceuticals Inc Transaction History

Saturn V Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.71 - $7.92 $185,209 - $218,607	27,602 Added 2.89%	982,458 $6.96 Billion
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $1.45 Million - $1.84 Million	-208,679 Reduced 17.93%	954,856 $6.72 Billion
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $6.54 Million - $9.75 Million	823,372 Added 242.05%	1,163,535 $9.7 Billion
Q4 2022 Feb 09, 2023	BUY	$10.5 - $14.2 $3.57 Million - $4.83 Million	340,163 New	340,163 $3.75 Billion

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Saturn V Capital Management LLC with notifications on news.